Mortalin mutations are not a frequent cause of early-onset Parkinson disease

Neurobiology of Aging

Volumn 34, Issue 11, 2013, Pages 2694.e19-2694.e20

  Freimann, Karen ^a   Zschiedrich, Katja ^a   Brüggemann, Norbert ^a   Grünewald, Anne ^a   Pawlack, Heike ^a   Hagenah, Johann ^a   Lohmann, Katja ^a   Klein, Christine ^a   Westenberger, Ana ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Early onset Parkinson disease; GRP75; HSPA9; Mitochondria; Mortalin

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; MORTALIN;

ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE; GENE FUNCTION; GENETIC VARIABILITY; GRP75 GENE; HSPA9 GENE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MITOCHONDRION; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; ADULT; AGED; EARLY-ONSET PARKINSON DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; GRP75; HSPA9; MALE; METABOLISM; MIDDLE AGED; MUTATION; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONSET AGE; OXYGEN CONSUMPTION; PATHOLOGY; TUMOR CELL LINE; YOUNG ADULT;

EARLY-ONSET PARKINSON DISEASE; GRP75; HSPA9; MITOCHONDRIA; MORTALIN;

ADULT; AGE OF ONSET; AGED; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MUTATION; NEUROBLASTOMA; OXYGEN CONSUMPTION; PARKINSON DISEASE; TRANSFECTION; YOUNG ADULT;

EID: 84881556250     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.05.021     Document Type: Article

References (11)

1. Burbulla L.F., Schelling C., Kato H., Rapaport D., Woitalla D., Schiesling C., Schulte C., Sharma M., Illig T., Bauer P., Jung S., Nordheim A., Schols L., Riess O., Kruger R. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis. Hum. Mol. Genet. 2010, 19:4437-4452.
2. Change N., Mercier G., Lucotte G. Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects. Genet. Test 2008, 12:333-339.
3. De Mena L., Coto E., Sanchez-Ferrero E., Ribacoba R., Guisasola L.M., Salvador C., Blazquez M., Alvarez V. Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease. J.Neural. Transm. 2009, 116:1289-1293.
4. Exome Variant Server. NHLBI GO Exome Sequencing Project (ESP), Seattle, WA.Available at: Accessed September 20,2012. http://evs.gs.washington.edu/EVS/.
5. Jin J., Hulette C., Wang Y., Zhang T., Pan C., Wadhwa R., Zhang J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol. Cell Proteomics 2006, 5:1193-1204.
6. Jin J., Li G.J., Davis J., Zhu D., Wang Y., Pan C., Zhang J. Identification of novel proteins associated with both alpha-synuclein and DJ-1. Mol. Cell Proteomics 2007, 6:845-859.
7. Li H.M., Niki T., Taira T., Iguchi-Ariga S.M., Ariga H. Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radic. Res. 2005, 39:1091-1099.
8. Rakovic A., Grunewald A., Voges L., Hofmann S., Orolicki S., Lohmann K., Klein C. PINK1-interacting proteins: proteomic analysis of overexpressed PINK1. Parkinsons Dis. 2011, 2011:153979.
9. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov. Disord. 2011, 26:1049-1055.
10. Schwarz J.M., Rodelsperger C., Schuelke M., Seelow D. Mutation taster evaluates disease-causing potential of sequence alterations. Nat. Methods 2010, 7:575-576.
11. Thusberg J., Olatubosun A., Vihinen M. Performance of mutation pathogenicity prediction methods on missense variants. Hum. Mutat. 2011, 32:358-368.